Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study

Clinical Genitourinary Cancer- United States

doi 10.1016/j.clgc.2016.03.019

Full Text

Abstract

Available in

Date

October 1, 2016

Authors

Mark W. Ball

Michael A. Gorin

Gunes Guner

Phillip M. Pierorazio

Publisher

Elsevier BV

Related search

A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients With Extensive Small-Cell Lung Cancer

Frontiers in Oncology

Cancer Research

Oncology

2014

English

Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association With Clinical Outcomes: A Pilot Study

European urology oncology

English

The Tumor Marker for Renal Cell Carcinoma

Japanese Journal of Urology

Urology

1987

English

P082 Circulating Mir-145 as a Marker of Therapeutic Response in Patients With Ankylosing Spondylitis Receiving Anti-TNF Therapy

2018

English

Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients

SpringerPlus

Multidisciplinary

2015

English

A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma

Journal of immunotherapy (Hagerstown, Md. : 1997)

English

Role of PDL1 as a Prognostic Marker in Renal Cell Carcinoma: A Prospective Observational Study in Eastern India

Therapeutic Advances in Urology

Urology

2019

English

KIM-1 as a Potential Serological/Urinological Tumor-Associated Marker of Renal Cell Carcinoma and Chemotherapy Nephrotoxicity

English

Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer

Scientific Reports

Multidisciplinary

2019

English

Amanote Research

Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study

Clinical Genitourinary Cancer- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients With Extensive Small-Cell Lung Cancer

Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association With Clinical Outcomes: A Pilot Study

The Tumor Marker for Renal Cell Carcinoma

P082 Circulating Mir-145 as a Marker of Therapeutic Response in Patients With Ankylosing Spondylitis Receiving Anti-TNF Therapy

Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients

A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma

Role of PDL1 as a Prognostic Marker in Renal Cell Carcinoma: A Prospective Observational Study in Eastern India

KIM-1 as a Potential Serological/Urinological Tumor-Associated Marker of Renal Cell Carcinoma and Chemotherapy Nephrotoxicity

Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer